November 7, 2024
TOPLINE: Both infliximab and adalimumab are safe and effective in achieving remission in patients with severe mucocutaneous Behçet syndrome, with adalimumab demonstrating a quicker response time; […]
November 7, 2024
The American College of Rheumatology (ACR) 2024 Annual Meeting is coming up in Washington, DC. From November 14 through November 19, this year’s gathering offers hundreds […]
November 4, 2024
With the discovery of autoantibodies and other risk factors for rheumatoid arthritis (RA), researchers developed clinical trials to see whether the disease can be prevented entirely. […]
November 4, 2024
Many people with rheumatologic diseases try supplements for symptom relief. Here’s what you need to know about some common picks. Dietary supplements were a $159 billion […]
November 1, 2024
Nearly two thirds of patients with rheumatic conditions switched to medical cannabis from medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids, with the substitution being […]
November 1, 2024
TOPLINE: In patients with giant cell arteritis (GCA), intravenous methylprednisolone compared with oral glucocorticoids alone does not improve visual acuity and increases the risk for diabetes […]
November 1, 2024
TOPLINE: The use of newer biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for treating juvenile idiopathic arthritis (JIA) rose sharply from 2001 to 2022, while […]
October 30, 2024
For people with severe symptomatic hip osteoarthritis, total hip replacement (THR) alleviates hip pain and improves function much more effectively than a resistance training program supervised […]
October 29, 2024
The European Alliance of Associations for Rheumatology (EULAR) is launching a new open-access journal — EULAR Rheumatology Open — in January 2025. The announcement is one of […]